<DOC>
	<DOCNO>NCT02949726</DOCNO>
	<brief_summary>The goal study find immune molecule , cell , gene involve development lymphedema ( LE ) , medicine target consider treating lymphedema . The hypothesis LE systemic , autoimmune-like disease initiate inflammatory cytokine induce surgery , radiation , possibly chemotherapy genetically susceptible patient .</brief_summary>
	<brief_title>Lymphatic Systemic Immunity Changes Post-radiation Lymphedema Development</brief_title>
	<detailed_description />
	<mesh_term>Lymphedema</mesh_term>
	<criteria>Participants must least 18 year age Participants must clinically diagnose breast cancer schedule axillary lymph node dissection ( ALND ) radiation treatment MD Anderson ( receive chemotherapy , mastectomy breastconserving surgery , ALND ( &gt; 10 node ) radiation treatment breast cancer , identify Drs . Mittendorf Shaitelman Nellie B. Connally Breast Cancer Center MD Anderson ) Ambulatory possess four limbs No prior radiation therapy Negative urine pregnancy test within 36 hour prior study drug administration , childbearing potential Females participant must complete Female Enrollment Form . Childbearing potential participant must agree use one medically accept form contraception period one month study participation . Female participant meet criterion nonchildbearing still complete Female Enrollment Form , restrict use contraception follow study participation . Participants know suspected allergy iodine Participants breastfeed , pregnant try become pregnant Severe underlie chronic illness disease ( breast cancer ) Participants capable keep moderately still image portion study session ( ~1 hour imaging )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>